Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13
- 31 October 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 124 (4), 761-770.e1
- https://doi.org/10.1016/j.jaci.2009.07.040
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Rα, IL-13Rα1, and γc regulates relative cytokine sensitivityThe Journal of Experimental Medicine, 2008
- Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17The Journal of Experimental Medicine, 2008
- Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challengeProceedings of the National Academy of Sciences of the United States of America, 2007
- Skin barrier function in atopic dermatitisCurrent Opinion in Pediatrics, 2007
- Interleukin-17 is a negative regulator of established allergic asthmaThe Journal of Experimental Medicine, 2006
- Cytokines or Their Antagonists for the Treatment of AsthmaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- T helper cell effector fates — who, how and where?Current Opinion in Immunology, 2006
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17Nature Immunology, 2005
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005